Latest Als News

Exultant Mining has completed key reconnaissance work at its Peak View Project in New South Wales, collecting 16 rock chip samples from historic prospects and securing land access agreements ahead of a planned drilling campaign in 2026.

New Frontier Minerals is wrapping up its first reverse circulation drilling at Harts Range, with samples now en route for assay analysis. Meanwhile, progress at the Big One Deposit mining lease signals advancing copper ambitions.

Neurizon Therapeutics has secured FDA clearance for its lead drug candidate NUZ-001 to enter the HEALEY ALS Platform Trial, marking a key regulatory milestone and setting the stage for patient enrollment in early 2026.

Stellar Resources has reported robust metallurgical test results from its Severn Deposit, highlighting strong tin recoveries and production of a clean, high-grade concentrate. These findings reinforce the project’s potential as a low-cost, high-quality tin source in a stable jurisdiction.

Solis Minerals has secured drilling permits for its Cinto Copper Project in southern Peru, setting the stage for a maiden diamond drilling campaign targeting promising geochemical and geophysical anomalies near major copper mines.

ALS Limited confirms a fully franked ordinary dividend of 19.4 cents per share and announces the Dividend Reinvestment Plan price at $21.97 with no discount applied.

ALS Limited has announced a partially franked interim dividend of 19.4 cents per share, payable mid-December, alongside a dividend reinvestment plan priced at $21.97 per share with no discount.

Critical Resources Limited has partnered with Canada's Pathway Group to accelerate permitting, funding, and stakeholder engagement for its Mavis Lake Lithium Project, aiming to cement its role in North America's lithium supply chain.

Ardea Resources updates its Definitive Feasibility Study for the Kalgoorlie Nickel Project, confirming a streamlined processing approach and a new sale product that could enhance project economics and market reach.

Neurizon Therapeutics has completed manufacturing three GMP registration batches of its lead ALS drug candidate NUZ-001 ahead of schedule, paving the way for FDA submissions and clinical trial enrollment.

Rimfire Pacific Mining has completed 54 air core holes at its Murga Exploration Target, with assays due mid-January and a maiden mineral resource estimate expected in March 2026. The program aims to expand Rimfire’s scandium inventory in Australia’s Fifield district.

Alara Resources has successfully commissioned its Al Wash-hi Majaza Copper Concentrator Plant in Oman, marking a key milestone as it begins copper-gold concentrate shipments and advances exploration across multiple licences.